From Yahoo News.A drug used for the treatment of a form of advanced kidney cancer is not being recommended for NHS-wide use, the National Institute for Health and Clinical Excellence (Nice) has said.
Issuing its final guidance, Nice said Everolimus - which is marketed as Afinitor and Novartis - "does not provide enough benefit to patients to justify its high cost".
Everolimus is used for the second line treatment of advanced renal cell carcinoma - a kidney cancer which starts in cells lining the small tubes which help to make urine.
Around 4,000 people are diagnosed with the advanced condition every year and not all these would be eligible for Everolimus, the institute said.
I wonder if private patients will be allowed to get it. I guess there is a list of drugs that the NHS cannot afford to give all their patients and quarrel between the NHS and some patients desperate for these drug continues... no one can be blamed.